HEADER VIRAL PROTEIN/IMMUNE SYSTEM 23-JAN-98 1A3R TITLE FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN TITLE 2 RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170) COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG2A 8F5 FAB (LIGHT CHAIN); COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: FAB FRAGMENT (PAPAIN DIGESTION); COMPND 5 SYNONYM: ANTIBODY 8F5; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: IGG2A 8F5 FAB (HEAVY CHAIN); COMPND 8 CHAIN: H; COMPND 9 FRAGMENT: FAB FRAGMENT (PAPAIN DIGESTION); COMPND 10 SYNONYM: ANTIBODY 8F5; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: HUMAN RHINOVIRUS CAPSID PROTEIN VP2; COMPND 13 CHAIN: P; COMPND 14 FRAGMENT: RESIDUES 156 - 170 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 7 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 MOL_ID: 3; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN RHINOVIRUS 2; SOURCE 11 ORGANISM_TAXID: 12130; SOURCE 12 STRAIN: SEROTYPE 2; SOURCE 13 OTHER_DETAILS: COMMON COLD VIRUS KEYWDS IMMUNOGLOBULIN, ANTIBODY, RHINOVIRUS, NEUTRALIZATION, CONTINUOUS KEYWDS 2 EPITOPE, COMPLEX (IMMUNOGLOBULIN-VIRAL PEPTIDE), VIRAL PROTEIN- KEYWDS 3 IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.TORMO,D.BLAAS,I.FITA REVDAT 4 16-OCT-24 1A3R 1 REMARK REVDAT 3 02-AUG-23 1A3R 1 REMARK LINK REVDAT 2 24-FEB-09 1A3R 1 VERSN REVDAT 1 29-APR-98 1A3R 0 JRNL AUTH J.TORMO,D.BLAAS,N.R.PARRY,D.ROWLANDS,D.STUART,I.FITA JRNL TITL CRYSTAL STRUCTURE OF A HUMAN RHINOVIRUS NEUTRALIZING JRNL TITL 2 ANTIBODY COMPLEXED WITH A PEPTIDE DERIVED FROM VIRAL CAPSID JRNL TITL 3 PROTEIN VP2. JRNL REF EMBO J. V. 13 2247 1994 JRNL REFN ISSN 0261-4189 JRNL PMID 8194515 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.TORMO,E.STADLER,T.SKERN,H.AUER,O.KANZLER,C.BETZEL,D.BLAAS, REMARK 1 AUTH 2 I.FITA REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A REMARK 1 TITL 2 NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2 REMARK 1 REF PROTEIN SCI. V. 1 1154 1992 REMARK 1 REFN ISSN 0961-8368 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.TORMO,I.FITA,O.KANZLER,D.BLAAS REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION STUDIES OF REMARK 1 TITL 2 THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL ANTIBODY REMARK 1 TITL 3 DIRECTED AGAINST HUMAN RHINOVIRUS SEROTYPE 2 REMARK 1 REF J.BIOL.CHEM. V. 265 16799 1990 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 28392 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.07 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4445 REMARK 3 BIN R VALUE (WORKING SET) : 0.2260 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3456 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 213 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.22 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.110 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.192 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.467 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.982 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.696 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1A3R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170355. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-91 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, ROTAVATA, AGROVATA REMARK 200 DATA SCALING SOFTWARE : CCP4 (AGROVATA, ROTAVATA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28392 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.18000 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: PDB ENTRY 1BBD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: FAB-PEPTIDE COMPLEX WAS CRYSTALLIZED REMARK 280 FROM 0.9 M SODIUM CITRATE, 25 MM SODIUM CHLORIDE, 50 MM TRIS-HCL, REMARK 280 PH 7.75, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.89500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.16000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.16000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.16000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.89500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.16000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 NH2: THE SYNTHETIC PEPTIDE HAS ITS C-TERMINAL END BLOCKED REMARK 400 WITH AN AMIDE GROUP. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU H 1 REMARK 465 GLY H 131 REMARK 465 ASP H 132 REMARK 465 THR H 133 REMARK 465 THR H 134 REMARK 465 GLY H 135 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG L 155 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 51 -32.10 68.74 REMARK 500 SER L 52 10.07 -143.31 REMARK 500 ALA L 84 -178.16 178.91 REMARK 500 ASN L 190 -54.89 -128.69 REMARK 500 ASN H 54 -7.36 -141.61 REMARK 500 ALA H 88 -178.62 -175.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 P 171 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PEPTIDE IS NUMBERED ACCORDING TO THE VIENNA ISOLATE REMARK 999 SEQUENCE (SKERN ET AL., NUCLEIC ACIDS RES., 13:2111- REMARK 999 2126(1985) DBREF 1A3R P 156 170 UNP P04936 POLG_HRV2 225 239 DBREF 1A3R L 1 214 PDB 1A3R 1A3R 1 214 DBREF 1A3R H 1 228 PDB 1A3R 1A3R 1 228 SEQRES 1 L 220 ASP ILE VAL MET THR GLN SER PRO SER SER LEU THR VAL SEQRES 2 L 220 THR THR GLY GLU LYS VAL THR MET THR CYS LYS SER SER SEQRES 3 L 220 GLN SER LEU LEU ASN SER ARG THR GLN LYS ASN TYR LEU SEQRES 4 L 220 THR TRP TYR GLN GLN LYS PRO GLY GLN SER PRO LYS LEU SEQRES 5 L 220 LEU ILE TYR TRP ALA SER THR ARG GLU SER GLY VAL PRO SEQRES 6 L 220 ASP ARG PHE THR GLY SER GLY SER GLY THR ASP PHE THR SEQRES 7 L 220 LEU SER ILE SER GLY VAL GLN ALA GLU ASP LEU ALA VAL SEQRES 8 L 220 TYR TYR CYS GLN ASN ASN TYR ASN TYR PRO LEU THR PHE SEQRES 9 L 220 GLY ALA GLY THR LYS LEU GLU LEU LYS ARG ALA ASP ALA SEQRES 10 L 220 ALA PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN SEQRES 11 L 220 LEU THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN SEQRES 12 L 220 ASN PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE SEQRES 13 L 220 ASP GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP SEQRES 14 L 220 THR ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SEQRES 15 L 220 SER THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS SEQRES 16 L 220 ASN SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SEQRES 17 L 220 SER PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 218 GLU VAL GLN LEU GLN GLN SER GLY ALA GLU LEU VAL ARG SEQRES 2 H 218 PRO GLY ALA SER VAL LYS LEU SER CYS THR THR SER GLY SEQRES 3 H 218 PHE ASN ILE LYS ASP ILE TYR ILE HIS TRP VAL LYS GLN SEQRES 4 H 218 ARG PRO GLU GLN GLY LEU GLU TRP ILE GLY ARG LEU ASP SEQRES 5 H 218 PRO ALA ASN GLY TYR THR LYS TYR ASP PRO LYS PHE GLN SEQRES 6 H 218 GLY LYS ALA THR ILE THR VAL ASP THR SER SER ASN THR SEQRES 7 H 218 ALA TYR LEU HIS LEU SER SER LEU THR SER GLU ASP THR SEQRES 8 H 218 ALA VAL TYR TYR CYS ASP GLY TYR TYR SER TYR TYR ASP SEQRES 9 H 218 MET ASP TYR TRP GLY PRO GLY THR SER VAL THR VAL SER SEQRES 10 H 218 SER ALA LYS THR THR ALA PRO SER VAL TYR PRO LEU ALA SEQRES 11 H 218 PRO VAL CYS GLY ASP THR THR GLY SER SER VAL THR LEU SEQRES 12 H 218 GLY CYS LEU VAL LYS GLY TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 218 LEU THR TRP ASN SER GLY SER LEU SER SER GLY VAL HIS SEQRES 14 H 218 THR PHE PRO ALA VAL LEU GLN SER ASP LEU TYR THR LEU SEQRES 15 H 218 SER SER SER VAL THR VAL THR SER SER THR TRP PRO SER SEQRES 16 H 218 GLN SER ILE THR CYS ASN VAL ALA HIS PRO ALA SER SER SEQRES 17 H 218 THR LYS VAL ASP LYS LYS ILE GLU PRO ARG SEQRES 1 P 16 VAL LYS ALA GLU THR ARG LEU ASN PRO ASP LEU GLN PRO SEQRES 2 P 16 THR GLU NH2 HET NH2 P 171 1 HETNAM NH2 AMINO GROUP FORMUL 3 NH2 H2 N FORMUL 4 HOH *213(H2 O) HELIX 1 1 ALA L 80 ASP L 82 5 3 HELIX 2 2 SER L 122 SER L 127 1 6 HELIX 3 3 LYS L 183 ARG L 188 1 6 HELIX 4 4 ILE H 29 ASP H 31 5 3 HELIX 5 5 PRO H 61 PHE H 63 5 3 HELIX 6 6 THR H 73 SER H 75 5 3 HELIX 7 7 SER H 84 ASP H 86 5 3 HELIX 8 8 ASN H 162 GLY H 164 5 3 HELIX 9 9 PRO H 213 SER H 215 5 3 HELIX 10 10 PRO P 164 LEU P 166 5 3 SHEET 1 A 4 MET L 4 SER L 7 0 SHEET 2 A 4 LYS L 18 SER L 25 -1 N LYS L 24 O THR L 5 SHEET 3 A 4 ASP L 70 SER L 76 -1 N ILE L 75 O VAL L 19 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 67 O ASP L 70 SHEET 1 B 5 SER L 10 THR L 14 0 SHEET 2 B 5 THR L 102 LYS L 107 1 N LYS L 103 O LEU L 11 SHEET 3 B 5 ALA L 84 ASN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 B 5 LEU L 33 GLN L 38 -1 N GLN L 38 O VAL L 85 SHEET 5 B 5 LYS L 45 ILE L 48 -1 N ILE L 48 O TRP L 35 SHEET 1 C 4 THR L 114 PHE L 118 0 SHEET 2 C 4 GLY L 129 ASN L 137 -1 N ASN L 137 O THR L 114 SHEET 3 C 4 MET L 175 THR L 182 -1 N LEU L 181 O ALA L 130 SHEET 4 C 4 VAL L 159 TRP L 163 -1 N SER L 162 O SER L 176 SHEET 1 D 4 SER L 153 ARG L 155 0 SHEET 2 D 4 ILE L 144 ILE L 150 -1 N ILE L 150 O SER L 153 SHEET 3 D 4 SER L 191 HIS L 198 -1 N THR L 197 O ASN L 145 SHEET 4 D 4 ILE L 205 ASN L 210 -1 N PHE L 209 O TYR L 192 SHEET 1 E 6 GLU H 10 VAL H 12 0 SHEET 2 E 6 THR H 107 VAL H 111 1 N THR H 110 O GLU H 10 SHEET 3 E 6 ALA H 88 TYR H 95 -1 N TYR H 90 O THR H 107 SHEET 4 E 6 TYR H 33 GLN H 39 -1 N GLN H 39 O VAL H 89 SHEET 5 E 6 LEU H 45 LEU H 51 -1 N LEU H 51 O ILE H 34 SHEET 6 E 6 THR H 57 TYR H 59 -1 N LYS H 58 O ARG H 50 SHEET 1 F 3 VAL H 18 THR H 23 0 SHEET 2 F 3 THR H 77 LEU H 82 -1 N LEU H 82 O VAL H 18 SHEET 3 F 3 ALA H 67 ASP H 72 -1 N ASP H 72 O THR H 77 SHEET 1 G 2 ASP H 93 TYR H 96 0 SHEET 2 G 2 MET H 100A TRP H 103 -1 N TYR H 102 O GLY H 94 SHEET 1 H 4 SER H 120 LEU H 124 0 SHEET 2 H 4 SER H 137 TYR H 147 -1 N LYS H 145 O SER H 120 SHEET 3 H 4 TYR H 185 THR H 194 -1 N VAL H 193 O VAL H 138 SHEET 4 H 4 VAL H 171 THR H 173 -1 N HIS H 172 O SER H 190 SHEET 1 I 3 THR H 153 TRP H 157 0 SHEET 2 I 3 THR H 206 HIS H 212 -1 N ALA H 211 O THR H 153 SHEET 3 I 3 THR H 217 LYS H 222 -1 N LYS H 221 O CYS H 208 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 3 CYS L 214 CYS H 128 1555 1555 2.04 SSBOND 4 CYS H 22 CYS H 92 1555 1555 2.02 SSBOND 5 CYS H 142 CYS H 208 1555 1555 2.03 LINK C GLU P 170 N NH2 P 171 1555 1555 1.33 CISPEP 1 SER L 7 PRO L 8 0 -0.62 CISPEP 2 TYR L 94 PRO L 95 0 -0.31 CISPEP 3 TYR L 140 PRO L 141 0 -0.12 CISPEP 4 PHE H 148 PRO H 149 0 -0.90 CISPEP 5 GLU H 150 PRO H 151 0 0.10 CISPEP 6 TRP H 199 PRO H 200 0 0.18 CISPEP 7 GLN P 167 PRO P 168 0 -0.41 SITE 1 AC1 1 GLU P 170 CRYST1 71.790 76.320 92.320 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013930 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013103 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010832 0.00000